Fonte: Atherosclerosis Supplements. Nome do evento: International Symposium on Atherosclerosis. Unidade: FCF
Assuntos: DIABETES MELLITUS, LIPOPROTEÍNAS
ABNT
DINA, Clederson Henry et al. Ability of HDL to receive lipids from an artificial lipoprotein model in diabetic patients with or without coronary artery disease. Atherosclerosis Supplements. Amsterdam: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 25 maio 2024. , 2006APA
Dina, C. H., Amâncio, R. F., Hueb, W. A., Lopes, N. H., Rodrigues, M. R., Latrilha, M. da C. de M., & Maranhão, R. C. (2006). Ability of HDL to receive lipids from an artificial lipoprotein model in diabetic patients with or without coronary artery disease. Atherosclerosis Supplements. Amsterdam: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.NLM
Dina CH, Amâncio RF, Hueb WA, Lopes NH, Rodrigues MR, Latrilha M da C de M, Maranhão RC. Ability of HDL to receive lipids from an artificial lipoprotein model in diabetic patients with or without coronary artery disease. Atherosclerosis Supplements. 2006 ; 7( 3): 347 res.We-P11:8.[citado 2024 maio 25 ]Vancouver
Dina CH, Amâncio RF, Hueb WA, Lopes NH, Rodrigues MR, Latrilha M da C de M, Maranhão RC. Ability of HDL to receive lipids from an artificial lipoprotein model in diabetic patients with or without coronary artery disease. Atherosclerosis Supplements. 2006 ; 7( 3): 347 res.We-P11:8.[citado 2024 maio 25 ]